Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | HCID 14430629 | HCID 14430629 | — |
| Reactant | Aluminium lithium hydride | HCID 21226445 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 70245767 | HCID 70245767 | 55.4% |
Reaction Steps
A solution of (2R,11aS)-2-(tert-butyldimethylsilyloxy)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5,11-dione (34.6 g) in tetrahydrofuran (100 ml) was dropwise added to a suspension of lithium aluminum hydride (4.2 g) in tetrahydrofuran (200 ml) at 0° C. over 15 minutes in a nitrogen gas atmosphere, followed by stirring at room temperature for one hour and at 50° C. for one hour. After ice-cooling the reaction solution, 30 ml of ethyl acetate and 8 ml of a saturated aqueous ammonium chloride solution were added to the reaction solution, the mixture was stirred for 30 minutes and the precipitates separated out were filtered off. The filtrate was dried, concentrated under reduced pressure and the resulting residue was recrystallized from ethyl acetate to give 18.4 g (yield 55.3%) of the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06225306B1 |
|---|
| Source dataset | uspto-grants-2001_05 |
|---|
| ORD ID | ord-6c6af8879ee04d2f9ffbd406070a22ac |
|---|
| Source note | uspto-grants-2001_05 |
|---|